These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37898095)

  • 1. GLUT-1 changes in paediatric Huntington disease brain cortex and fibroblasts: an observational case-control study.
    Tramutola A; Bakels HS; Perrone F; Di Nottia M; Mazza T; Abruzzese MP; Zoccola M; Pagnotta S; Carrozzo R; de Bot ST; Perluigi M; van Roon-Mom WMC; Squitieri F
    EBioMedicine; 2023 Nov; 97():104849. PubMed ID: 37898095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis.
    Fusilli C; Migliore S; Mazza T; Consoli F; De Luca A; Barbagallo G; Ciammola A; Gatto EM; Cesarini M; Etcheverry JL; Parisi V; Al-Oraimi M; Al-Harrasi S; Al-Salmi Q; Marano M; Vonsattel JG; Sabatini U; Landwehrmeyer GB; Squitieri F
    Lancet Neurol; 2018 Nov; 17(11):986-993. PubMed ID: 30243861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Spazio Huntington": Tracing the Early Motor, Cognitive and Behavioral Profiles of Kids with Proven Pediatric Huntington Disease and Expanded Mutations > 80 CAG Repeats.
    Graziola F; Maffi S; Grasso M; Garone G; Migliore S; Scaricamazza E; Ceccarelli C; Casella M; Busi L; D'Alessio B; De Luca A; Colafati GS; Sabatini U; Capuano A; Squitieri F
    J Pers Med; 2022 Jan; 12(1):. PubMed ID: 35055435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain structure in juvenile-onset Huntington disease.
    Tereshchenko A; Magnotta V; Epping E; Mathews K; Espe-Pfeifer P; Martin E; Dawson J; Duan W; Nopoulos P
    Neurology; 2019 Apr; 92(17):e1939-e1947. PubMed ID: 30971481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidities and clinical outcomes in adult- and juvenile-onset Huntington's disease: a study of linked Swedish National Registries (2002-2019).
    Furby H; Moore S; Nordstroem AL; Houghton R; Lambrelli D; Graham S; Svenningsson P; Petersén Å
    J Neurol; 2023 Feb; 270(2):864-876. PubMed ID: 36253622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare resource utilization and cost among individuals with late-onset versus adult-onset Huntington's disease: a claims‑based retrospective cohort study.
    To TM; Ta JT; Patel AM; Arndorfer S; Abbass IM; Gandhy R
    J Med Econ; 2023; 26(1):862-870. PubMed ID: 37350423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Making (anti-) sense out of huntingtin levels in Huntington disease.
    Evers MM; Schut MH; Pepers BA; Atalar M; van Belzen MJ; Faull RL; Roos RA; van Roon-Mom WM
    Mol Neurodegener; 2015 Apr; 10():21. PubMed ID: 25928884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association between CAG Repeat Length and Age of Onset of Juvenile-Onset Huntington's Disease.
    Schultz JL; Moser AD; Nopoulos PC
    Brain Sci; 2020 Aug; 10(9):. PubMed ID: 32825467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential control of the functional cell surface expression and content of hexose transporter GLUT-1 by glucose and glucose metabolism in murine fibroblasts.
    Ortiz PA; Haspel HC
    Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):67-72. PubMed ID: 8216241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor.
    Zhao S; Kuge Y; Mochizuki T; Takahashi T; Nakada K; Sato M; Takei T; Tamaki N
    J Nucl Med; 2005 Apr; 46(4):675-82. PubMed ID: 15809491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat.
    Ruocco HH; Bonilha L; Li LM; Lopes-Cendes I; Cendes F
    J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):130-5. PubMed ID: 17615168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of primary congenital hypothyroidism upon expression of genes mediating murine brain glucose uptake.
    Khan JY; Rajakumar RA; Devaskar UP; Weissfeld LA; Devaskar SU
    Pediatr Res; 1999 May; 45(5 Pt 1):718-25. PubMed ID: 10231871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II.
    Ong LC; Jin Y; Song IC; Yu S; Zhang K; Chow PK
    Acta Radiol; 2008 Dec; 49(10):1145-53. PubMed ID: 18979289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathological Comparison of Adult Onset and Juvenile Huntington's Disease with Cerebellar Atrophy: A Report of a Father and Son.
    Latimer CS; Flanagan ME; Cimino PJ; Jayadev S; Davis M; Hoffer ZS; Montine TJ; Gonzalez-Cuyar LF; Bird TD; Keene CD
    J Huntingtons Dis; 2017; 6(4):337-348. PubMed ID: 29036832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-frequency stimulation of rat fast-twitch muscle enhances the expression of hexokinase II and both the translocation and expression of glucose transporter 4 (GLUT-4).
    Hofmann S; Pette D
    Eur J Biochem; 1994 Jan; 219(1-2):307-15. PubMed ID: 8306997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma.
    Park SG; Lee JH; Lee WA; Han KM
    Nucl Med Biol; 2012 Nov; 39(8):1167-72. PubMed ID: 22901702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity of cognitive impairment in juvenile and late-onset Huntington disease.
    Gómez-Tortosa E; del Barrio A; García Ruiz PJ; Pernaute RS; Benítez J; Barroso A; Jiménez FJ; García Yébenes J
    Arch Neurol; 1998 Jun; 55(6):835-43. PubMed ID: 9626775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between FDG uptake and expressions of glucose transporter type 1, type 3, and hexokinase-II in Reed-Sternberg cells of Hodgkin lymphoma.
    Shim HK; Lee WW; Park SY; Kim H; Kim SE
    Oncol Res; 2009; 17(7):331-7. PubMed ID: 19408578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical presentation of juvenile Huntington disease.
    Ruocco HH; Lopes-Cendes I; Laurito TL; Li LM; Cendes F
    Arq Neuropsiquiatr; 2006 Mar; 64(1):5-9. PubMed ID: 16622544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Widespread heterogeneous neuronal loss across the cerebral cortex in Huntington's disease.
    Nana AL; Kim EH; Thu DC; Oorschot DE; Tippett LJ; Hogg VM; Synek BJ; Roxburgh R; Waldvogel HJ; Faull RL
    J Huntingtons Dis; 2014; 3(1):45-64. PubMed ID: 25062764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.